[Present state of the multidisciplinary treatment of locoregionally advanced breast cancer].
Recent intensive combined chemotherapy regimen including adriamycin is very effective in objective regression in locoregional and distant metastatic lesions of breast cancer. This report analyses our results in treating stage III b and IV breast cancer patients by a series of treatment, namely, intensive induction therapy, subsequent mastectomy and radiotherapy, and maintenance systemic therapies such as chemical, hormonal and/or immunotherapy. And the results about similar combined treatment program in the recent reports are also discussed. This kind of multidisciplinary treatment for the patient with locoregionally advanced breast cancer (stage III b) can be expected to improve long-term results.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008408:Mastectomy / Q000401:mortality; D009367:Neoplasm Staging; D011379:Prognosis
D001500:BCG Vaccine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil